Royal Marsden NHS Foundation Trust
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
PPALM-Palm Oil and Pentoxifylline Against Late Morbidity
Phase 2
Completed
- Conditions
- Long-term Adverse Effects of Radiotherapy for Pelvic Cancer
- Interventions
- Drug: Matching placebos
- First Posted Date
- 2014-09-03
- Last Posted Date
- 2019-12-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 62
- Registration Number
- NCT02230800
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours
Phase 1
Active, not recruiting
- Conditions
- Solid Tumour Refractory to Conventional Treatment
- Interventions
- Radiation: Palliative radiotherapy
- First Posted Date
- 2014-08-22
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 87
- Registration Number
- NCT02223923
- Locations
- 🇬🇧
Guys and St Thomas' NHS Foundation Trust, London, United Kingdom
🇬🇧University College Hospital, London, United Kingdom
🇬🇧Royal Marsden Hospital, London, United Kingdom
A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.
Phase 1
Completed
- Conditions
- Advanced Cancer
- Interventions
- Drug: AZD2014 3 on/4 off & weekly paclitaxelDrug: AZD2014 2 on/5 off & weekly paclitaxel
- First Posted Date
- 2014-07-17
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 90
- Registration Number
- NCT02193633
- Locations
- 🇬🇧
Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom
🇬🇧Royal Marsden Hospital, Sutton, Surrey, United Kingdom
🇬🇧Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery
Not Applicable
- Conditions
- Persistent Post-surgical PainNeuropathic PainCancer Pain
- Interventions
- Drug: Protective analgesiaOther: Pain educationBehavioral: Psychological supportProcedure: Paravertebral block/local anaesthetic infiltrationOther: Daily visits from pain team whilst in hospital
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2014-06-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 154
- Registration Number
- NCT02170415
- Locations
- 🇬🇧
The Royal Marsden Hospital, London, United Kingdom
Parotid-sparing IMRT for Nasopharyngeal Cancer
Completed
- Conditions
- Nasopharyngeal CancersIntensity Modulated Radiotherapy With Chemotherapy
- Interventions
- Radiation: Intensity modulated radiotherapy with chemotherapy
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 42
- Registration Number
- NCT02149641
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck
Completed
- Conditions
- Oropharyngeal Squamous Cell CancerHypopharyngeal Squamous Cell Cancer
- Interventions
- Radiation: Intensity modulated radiotherapy
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 120
- Registration Number
- NCT02149602
- Locations
- 🇬🇧
Head and Neck Unit, Royal Marsden Hospital, London, United Kingdom
The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife
Phase 2
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 20
- Registration Number
- NCT02145494
- Locations
- 🇬🇧
Royal Marsden NHS Foundation trust, London, United Kingdom
Rapid Medical Donation Programme for Breast Cancer
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2014-04-30
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 60
- Registration Number
- NCT02126800
- Locations
- 🇬🇧
Royal Marsden NHS Foundation Trust, London, United Kingdom
The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms"
Completed
- Conditions
- Cancer
- First Posted Date
- 2014-04-23
- Last Posted Date
- 2017-11-22
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 248
- Registration Number
- NCT02121626
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Feasibility of a Molecular Characterisation Approach to Treatment
- Conditions
- Advanced Gastrointestinal Cancers
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 200
- Registration Number
- NCT02112357
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London and Surrey, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath